Research and Markets: Valeant IMS Company Profile

Research and Markets (http://www.researchandmarkets.com/research/77d259/valeant_ims_compan) has announced the addition of the "Valeant IMS Company Profile" company profile to their offering.

This Company Profile gives you the authoritative insight into a company at a strategic and local level.

Each individual profile analyzes the critical components that make up a pharmaceutical company, providing you with a clear assessment of the relative strengths and weaknesses of a company's business strategy.

• Critical analyses provided by an in-house expert team
• 90+ full in-depth company profiles covering all major pharmaceutical companies worldwide including private companies
• Includes some Generic, Biotechnology and Drug Delivery companies
• Includes sales data on products and therapies
• In depth product and R&D reviews, including clinical trial, lifecycle management, competition and analysts forecasts
• Mergers and acquisitions; licensing agreements
• Forecasts and comments from leading financial analysts
• Companies' conferences, annual reports, press releases
• Comments from stockbrokers/analysts reports used throughout the profile and especially within the Strategy, Financial and Product sections

For more information visit http://www.researchandmarkets.com/research/77d259/valeant_ims_compan.

Source: IMS Health